Category: Drug development
Operationalizing Global Oncology Trials Catalyst Oncology accelerates innovation by aligning strategic insight, deep expertise, a global reach and flawless execution. Read Now 
Prioritizing Safety in Clinical Trials The Impact of Culture on Operational Success Effective collection and continuous monitoring of patient safety Read Now 
The Growing Complexity of Conducting Oncology Trials Changing regulations, challenging study designs, and globalization Early-phase trial designs are becoming more complex following Read Now 
The Evolving Landscape of Oncology Drug Development Increasing incidence rates and the rise of novel therapies Oncology is the largest therapeutic area Read Now 
Partnering with Functional Service Providers How culture drives success Consultants across industries suggest that a better corporate culture — one Read Now 
Leveraging Functional Service Providers for Enhanced Efficiency in Drug Development Watch this webinar to learn how functional service providers (FSPs) are transforming the clinical research Read Now 
Impacts of Project Optimus on Oncology Trial Costs Exploring creative financial solutions for biotechs Navigating the evolving landscape of early-phase drug development has Read Now 
Global Regulatory Strategy to Guide Your Oncology Program A well-planned regulatory strategy is critical to the successful launch of your product on a Read Now 
FDA Finalizes Project Optimus Guidance for Dosing and Expectations for First-in-Human Oncology Trials The past 18 months have been Read Now 
Catalyst Oncology Consulting Catalyst Oncology Consulting is focused solely on the development of new treatments in oncology. Catalyst Read Now